Pharma Mar, S.A.

BME:PHM 주식 보고서

시가총액: €1.3b

Pharma Mar 관리

관리 기준 확인 1/4

Pharma Mar CEO는 Jose Fernandez Sousa-Faro, Jan1986 에 임명되었습니다 의 임기는 38.83 년입니다. 는 € 81.89M 가치에 해당하는 회사 주식의 6.35% 직접 소유합니다. 81.89M. 경영진과 이사회의 평균 재임 기간은 각각 9.8 년과 2.4 년입니다.

주요 정보

Jose Fernandez Sousa-Faro

최고 경영자

n/a

총 보상

CEO 급여 비율n/a
CEO 임기38.8yrs
CEO 소유권6.4%
경영진 평균 재임 기간9.8yrs
이사회 평균 재임 기간2.4yrs

최근 관리 업데이트

Recent updates

Pharma Mar, S.A.'s (BME:PHM) Price Is Right But Growth Is Lacking After Shares Rocket 55%

Oct 16
Pharma Mar, S.A.'s (BME:PHM) Price Is Right But Growth Is Lacking After Shares Rocket 55%

Pharma Mar, S.A.'s (BME:PHM) Share Price Boosted 27% But Its Business Prospects Need A Lift Too

Jul 28
Pharma Mar, S.A.'s (BME:PHM) Share Price Boosted 27% But Its Business Prospects Need A Lift Too

Pharma Mar (BME:PHM) Will Pay A Larger Dividend Than Last Year At €0.65

Jun 01
Pharma Mar (BME:PHM) Will Pay A Larger Dividend Than Last Year At €0.65

Pharma Mar, S.A.'s (BME:PHM) Shares Bounce 29% But Its Business Still Trails The Industry

May 28
Pharma Mar, S.A.'s (BME:PHM) Shares Bounce 29% But Its Business Still Trails The Industry

Pharma Mar, S.A. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Mar 03
Pharma Mar, S.A. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Here's Why Pharma Mar (BME:PHM) Has A Meaningful Debt Burden

Jan 25
Here's Why Pharma Mar (BME:PHM) Has A Meaningful Debt Burden

Pharma Mar, S.A. (BME:PHM) Shares Could Be 30% Below Their Intrinsic Value Estimate

Apr 28
Pharma Mar, S.A. (BME:PHM) Shares Could Be 30% Below Their Intrinsic Value Estimate

We Believe That Pharma Mar's (BME:PHM) Weak Earnings Are A Good Indicator Of Underlying Profitability

Mar 08
We Believe That Pharma Mar's (BME:PHM) Weak Earnings Are A Good Indicator Of Underlying Profitability

Analyst Forecasts Just Became More Bearish On Pharma Mar, S.A. (BME:PHM)

Mar 05
Analyst Forecasts Just Became More Bearish On Pharma Mar, S.A. (BME:PHM)

Pharma Mar (BME:PHM) Has A Rock Solid Balance Sheet

Feb 09
Pharma Mar (BME:PHM) Has A Rock Solid Balance Sheet

We Think Pharma Mar (BME:PHM) Can Manage Its Debt With Ease

Oct 27
We Think Pharma Mar (BME:PHM) Can Manage Its Debt With Ease

An Intrinsic Calculation For Pharma Mar, S.A. (BME:PHM) Suggests It's 21% Undervalued

Sep 27
An Intrinsic Calculation For Pharma Mar, S.A. (BME:PHM) Suggests It's 21% Undervalued

Does Pharma Mar (BME:PHM) Have A Healthy Balance Sheet?

Jul 15
Does Pharma Mar (BME:PHM) Have A Healthy Balance Sheet?

Growth Investors: Industry Analysts Just Upgraded Their Pharma Mar, S.A. (BME:PHM) Revenue Forecasts By 24%

May 04
Growth Investors: Industry Analysts Just Upgraded Their Pharma Mar, S.A. (BME:PHM) Revenue Forecasts By 24%

Pharma Mar (BME:PHM) Has A Pretty Healthy Balance Sheet

Apr 11
Pharma Mar (BME:PHM) Has A Pretty Healthy Balance Sheet

There Is A Reason Pharma Mar, S.A.'s (BME:PHM) Price Is Undemanding

Mar 16
There Is A Reason Pharma Mar, S.A.'s (BME:PHM) Price Is Undemanding

Is Pharma Mar (BME:PHM) Using Too Much Debt?

Jan 09
Is Pharma Mar (BME:PHM) Using Too Much Debt?

Pharma Mar (BME:PHM) Seems To Use Debt Quite Sensibly

Sep 08
Pharma Mar (BME:PHM) Seems To Use Debt Quite Sensibly

News Flash: Analysts Just Made A Meaningful Upgrade To Their Pharma Mar, S.A. (BME:PHM) Forecasts

Aug 03
News Flash: Analysts Just Made A Meaningful Upgrade To Their Pharma Mar, S.A. (BME:PHM) Forecasts

Here's Why I Think Pharma Mar (BME:PHM) Is An Interesting Stock

May 31
Here's Why I Think Pharma Mar (BME:PHM) Is An Interesting Stock

Pharma Mar (BME:PHM) Has A Rock Solid Balance Sheet

May 10
Pharma Mar (BME:PHM) Has A Rock Solid Balance Sheet

Is Pharma Mar, S.A. (BME:PHM) Expensive For A Reason? A Look At Its Intrinsic Value

Apr 08
Is Pharma Mar, S.A. (BME:PHM) Expensive For A Reason? A Look At Its Intrinsic Value

Announcing: Pharma Mar (BME:PHM) Stock Increased An Energizing 231% In The Last Five Years

Jan 14
Announcing: Pharma Mar (BME:PHM) Stock Increased An Energizing 231% In The Last Five Years

Is Pharma Mar (BME:PHM) A Risky Investment?

Nov 19
Is Pharma Mar (BME:PHM) A Risky Investment?

CEO

Jose Fernandez Sousa-Faro

38.8yrs

테뉴어

€294,000

보상

Mr. José María Fernández Sousa-Faro, Ph D., founded Pharma Mar, S.A.U. in 1986. He Founded Noscira, S.A., in 2000.He serves as the Chief Executive Officer and President of Pharma Mar, S.A.U. He serves as...

리더십 팀

이름위치테뉴어보상소유권
Jose Fernandez Sousa-Faro
Founder38.8yrs€294.00k6.35%
€ 81.9m
Pedro Fernandez Puentes
Executive Vice-Chairmanno data€124.00k데이터 없음
Juan Carretero
Founderno data데이터 없음데이터 없음
María de Francia Caballero
Chief Financial Officer24.8yrs데이터 없음데이터 없음
José Moreno Martinez-Losa
Head of Capital Markets & Investor Relations9.8yrs데이터 없음데이터 없음
Juan Pulido
General Counsel & Secretary of the Board of Directors5.2yrs데이터 없음데이터 없음
Sandra Sanchez
Global Compliance Head4.5yrs데이터 없음데이터 없음
Lara Vadillo
Communication Directorno data데이터 없음데이터 없음
Belén Veramendi
Director of Corporate Development2.8yrs데이터 없음데이터 없음
Luis Cuenca
Director of Human Resources & IT21.3yrs데이터 없음데이터 없음
Pascal Besman
Chief Operating Officer of Pharmar U.S.no data데이터 없음데이터 없음
Maria Arce
Global Head of Regulatory Affairsno data데이터 없음데이터 없음

9.8yrs

평균 재임 기간

경험이 풍부한 관리: PHM 의 관리팀은 노련하고 경험 (평균 재직 기간 9.8 년)입니다.

이사회 구성원

이름위치테뉴어보상소유권
Jose Fernandez Sousa-Faro
Founderno data€294.00k6.35%
€ 81.9m
Pedro Fernandez Puentes
Executive Vice-Chairmanno data€124.00k데이터 없음
Eduardo Serra Rexach
Independent Other External Director3.8yrs€35.00k데이터 없음
M. Solchaga Catalan
Independent Other External Directorno data€35.00k데이터 없음
Montserrat Andrade Detrell
Proprietary Directorno data€34.00k5.44%
€ 70.2m
Blanca Hernandez Rodriguez
Independent Director5.8yrs데이터 없음데이터 없음
Maria Sandra Mera
Representative Proprietary Director3.9yrs데이터 없음데이터 없음
Rosa Maria Alonso
Independent Director2.4yrs데이터 없음데이터 없음
Mariano Rodriguez
Independent Coordinating Director2.4yrs데이터 없음데이터 없음
Emiliano Aller
Independent Director2.4yrs데이터 없음데이터 없음
Fernando Santos
Independent Other External Directorno data데이터 없음데이터 없음
Soledad Miranda
Independent Director1.5yrs데이터 없음데이터 없음

2.4yrs

평균 재임 기간

경험이 풍부한 이사회: PHM 의 이사회는 경험(평균 재직 기간 2.4 년)으로 간주되지 않으므로 새 이사회가 필요합니다.